List of seasonal influenza vaccines - Wikipedia
Seasonal influenza vaccine brands include Fluzone/Fluzone Quadrivalent [1] and Vaxigrip/VaxigripTetra, [2] Influvac and Optaflu. Fluenz, Flumist and their quadrivalent formulations are nasal attenuated vaccines by AstraZeneca. Fluarix, Flulaval and their quadrivalent formulations are split virus inactivated vaccines by GlaxoSmithKline. [7]
How Influenza (Flu) Vaccines Are Made | Influenza (Flu) | CDC
Nov 3, 2022 · All commercially available flu vaccines in the United States are made by private sector manufacturers. Different manufacturers use different production technologies, but all flu vaccines meet FDA safety and effectiveness requirements.
Seasonal Influenza Vaccine Supply for the U.S. 2024-2025 …
Flu vaccine is produced by private manufacturers, so supply depends on manufacturers. For the 2024-2025 flu season, vaccine manufacturers estimate supplying the U.S. with 148 million doses. All flu vaccines for the 2024-2025 season will be trivalent (three component).
Vaccine Manufacturers | Immunize.org
Aug 29, 2024 · Find contact information for vaccine manufacturers plus links to official websites.
2023-2024 Influenza Season Vaccine Supply | Influenza (Flu) | CDC
Flu vaccine is produced by private manufacturers, so supply depends on manufacturers. Vaccine manufacturers have projected that they will supply the United States with as many as 156.2 million to 170 million doses of influenza vaccines for the 2023-2024 season.
Jul 24, 2024 · Vaccination providers should consult FDA-approved prescribing information for 2024-25 influenza vaccines for the most complete and updated information, including, but not limited to, indications, contraindications, warnings, and precautions.
Vaccine Supply & Distribution Information for Health Care Providers
Nov 13, 2024 · Flu vaccine is produced by private manufacturers, so supply depends on manufacturers. Vaccine manufacturers have projected that they will supply the United States with 148 million doses of influenza vaccines for the 2024-2025 season.
age 18 through 64 years who are on immunosuppression medication regimens may receive either high-dose IIV (HD-IIV) or adjuvanted IIV (aIIV) influenza vaccine as opions for influenza vaccination, without a preference over other age-appropriate IIVs or RIVs.
Flu - GSK US
How are flu vaccines manufactured? Today’s flu vaccines are made in chicken eggs, cell culture or through recombinant protein expression. Globally, egg-based manufacturing has been used for over 70 years and is the most common flu vaccine manufacturing process. 8
GSK begins shipping influenza vaccine doses for 2024-25 season
Jul 11, 2024 · GSK plc (LSE/NYSE: GSK) today announced it has started shipping doses of its trivalent influenza vaccines to US healthcare providers and pharmacies in preparation for the 2024-25 flu season. This immediately follows a licensing and lot-release approval from the US Food and Drug Administration (FDA).